Published in Radiology on March 01, 1997
Combined magnetic resonance imaging and spectroscopic imaging approach to molecular imaging of prostate cancer. J Magn Reson Imaging (2002) 2.64
Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol (2008) 2.23
Advancements in MR imaging of the prostate: from diagnosis to interventions. Radiographics (2011) 2.17
Prostate cancer: sextant localization at MR imaging and MR spectroscopic imaging before prostatectomy--results of ACRIN prospective multi-institutional clinicopathologic study. Radiology (2009) 1.48
Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. Neoplasia (2000) 1.34
MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results. Eur Radiol (2004) 1.31
Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am (2008) 1.24
Prostate cancer: diagnosis and staging. Asian J Androl (2008) 1.21
Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5 T for local staging of elevated risk prostate cancer. Can Urol Assoc J (2010) 1.19
Semi-automatic deformable registration of prostate MR images to pathological slices. J Magn Reson Imaging (2010) 1.17
Prostate cancer: a comparative study of 11C-choline PET and MR imaging combined with proton MR spectroscopy. Eur J Nucl Med Mol Imaging (2005) 1.17
MR imaging of the prostate in clinical practice. MAGMA (2008) 1.15
MR-compatible assistance system for punction in a high-field system: device and feasibility of transgluteal biopsies of the prostate gland. Eur Radiol (2006) 1.10
Multiparametric magnetic resonance imaging of prostate cancer. Indian J Radiol Imaging (2012) 1.09
Can pre-operative contrast-enhanced dynamic MR imaging for prostate cancer predict microvessel density in prostatectomy specimens? Eur Radiol (2003) 1.08
Pretreatment endorectal magnetic resonance imaging and magnetic resonance spectroscopic imaging features of prostate cancer as predictors of response to external beam radiotherapy. Int J Radiat Oncol Biol Phys (2008) 1.05
Prostate MR imaging at high-field strength: evolution or revolution? Eur Radiol (2005) 1.01
Prostate cancer: role of pretreatment MR in predicting outcome after external-beam radiation therapy--initial experience. Radiology (2008) 0.99
Correlation of phospholipid metabolites with prostate cancer pathologic grade, proliferative status and surgical stage - impact of tissue environment. NMR Biomed (2011) 0.99
Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer. Eur Radiol (2010) 0.97
Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRI. Int J Radiat Oncol Biol Phys (2010) 0.90
Comparison of pelvic phased-array versus endorectal coil magnetic resonance imaging at 3 Tesla for local staging of prostate cancer. Yonsei Med J (2012) 0.89
Imaging and evaluation of patients with high-risk prostate cancer. Nat Rev Urol (2015) 0.87
The incremental value of contrast-enhanced MRI in the detection of biopsy-proven local recurrence of prostate cancer after radical prostatectomy: effect of reader experience. AJR Am J Roentgenol (2012) 0.87
Prostate cancer: serum and tissue markers. Rev Urol (2001) 0.85
Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. J Endourol (2008) 0.85
Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiat Oncol (2015) 0.83
Role of magnetic resonance methods in the evaluation of prostate cancer: an Indian perspective. MAGMA (2008) 0.82
Value of magnetic resonance imaging in prostate cancer diagnosis. World J Urol (2007) 0.81
Are histopathological features of prostate cancer lesions associated with identification of extracapsular extension on magnetic resonance imaging? BJU Int (2010) 0.79
Incremental value of magnetic resonance imaging in the advanced management of prostate cancer. World J Radiol (2009) 0.78
Molecular research in urology 2014: update on PET/MR imaging of the prostate. Int J Mol Sci (2014) 0.78
Clinically low-risk prostate cancer: evaluation with transrectal doppler ultrasound and functional magnetic resonance imaging. Clinics (Sao Paulo) (2011) 0.78
Risk stratification of prostate cancer: integrating multiparametric MRI, nomograms and biomarkers. Future Oncol (2016) 0.78
Definitive 3D-CRT for clinically localized prostate cancer: modifications of the clinical target volume following a prostate MRI and the clinical benefits. Springerplus (2015) 0.77
Multiparametric magnetic resonance imaging and frozen-section analysis efficiently predict upgrading, upstaging, and extraprostatic extension in patients undergoing nerve-sparing robotic-assisted radical prostatectomy. Medicine (Baltimore) (2016) 0.75
Planning primary therapy. Cancer Imaging (2000) 0.75
Local staging of prostate cancer: comparative accuracy of T2-weighted endorectal MR imaging and transrectal ultrasound. Clin Imaging (2012) 0.75
Long-term oncological outcome in men with T3 prostate cancer: radical prostatectomy versus external-beam radiation therapy at a single institution. Int J Clin Oncol (2013) 0.75
Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology (2001) 6.19
Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA (1989) 5.66
Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: risk-factor analysis. Lancet (2001) 5.28
Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet (1995) 5.02
Seropositivity for HIV and the development of AIDS or AIDS related condition: three year follow up of the San Francisco General Hospital cohort. Br Med J (Clin Res Ed) (1988) 4.03
Natural history of HIV infection. AIDS (1989) 3.75
HIV seroconversion in intravenous drug users in San Francisco, 1985-1990. AIDS (1994) 3.67
Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology (1996) 2.95
Sextant localization of prostate cancer: comparison of sextant biopsy, magnetic resonance imaging and magnetic resonance spectroscopic imaging with step section histology. J Urol (2000) 2.73
Risk factors for AIDS and HIV seropositivity in homosexual men. Am J Epidemiol (1987) 2.62
Comparison of custom and prefabricated orthoses in the initial treatment of proximal plantar fasciitis. Foot Ankle Int (1999) 2.37
Prostate cancer: localization with three-dimensional proton MR spectroscopic imaging--clinicopathologic study. Radiology (1999) 2.32
The impact of HIV on chronic kidney disease outcomes. Kidney Int (2007) 2.22
Imaging prostate cancer. Radiol Clin North Am (2000) 2.20
Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial. Ann Intern Med (1997) 2.17
Hormonal risk factors in testicular cancer. A case-control study. Am J Epidemiol (1986) 1.97
Association of renal agenesis and mullerian duct anomalies. J Comput Assist Tomogr (2000) 1.95
Vasculogenic impotence evaluated by high-resolution ultrasonography and pulsed Doppler spectrum analysis. Radiology (1985) 1.93
Evaluation of asymptomatic microscopic hematuria in adults: the American Urological Association best practice policy--part I: definition, detection, prevalence, and etiology. Urology (2001) 1.83
Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. Radiology (1999) 1.82
Prostate cancer imaging. Acta Radiol (2008) 1.82
Management of the fetus with congenital hydronephrosis. J Pediatr Surg (1982) 1.79
Prehospital stability of diazepam and lorazepam. Am J Emerg Med (1999) 1.72
Sensitivity of treponemal tests for detecting prior treated syphilis during human immunodeficiency virus infection. J Infect Dis (1990) 1.67
Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab (1996) 1.64
Lipomatous tumors and tumors with fatty component: MR imaging potential and comparison of MR and CT results. Radiology (1985) 1.60
Mortality associated with mode of presentation in the acquired immune deficiency syndrome. J Natl Cancer Inst (1984) 1.59
The underreporting of deaths of American Indian children in California, 1979 through 1993. Am J Public Health (1997) 1.58
Permanent declines in pulmonary function following pneumonia in human immunodeficiency virus-infected persons. The Pulmonary Complications of HIV Infection Study Group. Am J Respir Crit Care Med (2000) 1.56
Radiological evaluation of lymph node metastases in patients with cervical cancer. A meta-analysis. JAMA (1997) 1.56
Prostate cancer: effect of postbiopsy hemorrhage on interpretation of MR images. Radiology (1995) 1.53
Further studies on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. Phytother Res (2004) 1.52
Impact of the ovulatory cycle on virologic and immunologic markers in HIV-infected women. J Infect Dis (2000) 1.51
Sonographic findings in perforation of the gallbladder. AJR Am J Roentgenol (1982) 1.51
Magnetic resonance imaging with respiratory gating: techniques and advantages. AJR Am J Roentgenol (1984) 1.46
Assessment of prognosis in patients with community-acquired pneumonia who require mechanical ventilation. Chest (2000) 1.43
Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis. Neurology (1999) 1.42
Asymptomatic microscopic hematuria in adults: summary of the AUA best practice policy recommendations. Am Fam Physician (2001) 1.42
The future of research in genitourinary radiology: through the looking glass--a view from the Society of Uroradiology. Radiology (1998) 1.41
Cervical carcinoma: computed tomography and magnetic resonance imaging for preoperative staging. Obstet Gynecol (1995) 1.39
Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases. Cancer (1981) 1.38
Quantitation of hepatitis C virus RNA in liver transplant recipients. Gastroenterology (1994) 1.37
Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology (2000) 1.32
The prostate: MR imaging and spectroscopy. Present and future. Radiol Clin North Am (2000) 1.32
Prostate volumes defined by magnetic resonance imaging and computerized tomographic scans for three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys (1996) 1.32
Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging. Radiology (1998) 1.30
Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS). Sex Transm Dis (1999) 1.27
Chance, concurrence, and clustering. Analysis of reviewers' recommendations on 1,000 submissions to the Journal of Clinical Investigation. J Clin Invest (1994) 1.27
Diagnosis of urethral diverticula in women: value of MR imaging. AJR Am J Roentgenol (1993) 1.25
Consequences of worksite hypertension screening. Differential changes in psychosocial function. Am J Med (1986) 1.25
MR imaging of the prostate gland: normal anatomy. AJR Am J Roentgenol (1987) 1.24
A pilot study on the clinical efficacy of Solanum xanthocarpum and Solanum trilobatum in bronchial asthma. J Ethnopharmacol (1999) 1.24
CT and MRI of pelvic varices in women. J Comput Assist Tomogr (1999) 1.21
Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms. Radiology (1986) 1.21
Reconstructing hominid Y evolution: X-homologous block, created by X-Y transposition, was disrupted by Yp inversion through LINE-LINE recombination. Hum Mol Genet (1998) 1.19
Radiologic staging in patients with endometrial cancer: a meta-analysis. Radiology (1999) 1.18
Progression of human immunodeficiency virus type 1 (HIV-1) infection among homosexual men in hepatitis B vaccine trial cohorts in Amsterdam, New York City, and San Francisco, 1978-1991. Am J Epidemiol (1994) 1.18
Complex adnexal masses: detection and characterization with MR imaging--multivariate analysis. Radiology (2000) 1.18
A serial study of new MS lesions and the white matter from which they arise. Neurology (1998) 1.17
Renal parenchymal disease: sonographic-histologic correlation. Radiology (1982) 1.17
Magnetic resonance imaging of developmental venous anomalies. AJR Am J Roentgenol (1985) 1.16
The potential impact of nuclear magnetic resonance imaging on cardiovascular diagnosis. Circulation (1983) 1.16
Do we truly see what we think we see? The role of cognitive bias in pathological interpretation. J Pathol (2008) 1.15
Effects of primary care coordination on public hospital patients. J Gen Intern Med (2000) 1.15
Prostatic carcinoma: staging by clinical assessment, CT, and MR imaging. Radiology (1987) 1.15
Complex fetal disorders: effect of MR imaging on management--preliminary clinical experience. Radiology (1999) 1.13
Serum albumin as a predictor of survival in HIV-infected women in the Women's Interagency HIV study. AIDS (2000) 1.13
Citrate as an in vivo marker to discriminate prostate cancer from benign prostatic hyperplasia and normal prostate peripheral zone: detection via localized proton spectroscopy. Urology (1995) 1.12
Localized prostate cancer: effect of hormone deprivation therapy measured by using combined three-dimensional 1H MR spectroscopy and MR imaging: clinicopathologic case-controlled study. Radiology (2001) 1.11
Müllerian duct anomalies: MR imaging evaluation. Radiology (1990) 1.11
Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology (1994) 1.10
Switching first-line disease-modifying therapy after failure: impact on the course of relapsing-remitting multiple sclerosis. Mult Scler (2008) 1.09
Immune activation markers and AIDS prognosis. AIDS (1991) 1.09
MR imaging of pathologic abdominal fluid collections. J Comput Assist Tomogr (1986) 1.08
Surrogate markers for survival in patients with AIDS and AIDS related complex treated with zidovudine. BMJ (1991) 1.08
Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn Reson Med (2001) 1.08
Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Metab (1996) 1.07
Anatomy and pathology of the male pelvis by magnetic resonance imaging. AJR Am J Roentgenol (1983) 1.06
Clinical application of BASING and spectral/spatial water and lipid suppression pulses for prostate cancer staging and localization by in vivo 3D 1H magnetic resonance spectroscopic imaging. Magn Reson Med (2000) 1.06
Risk of low birth weight infants among black and white parents. Obstet Gynecol (1998) 1.06
MRI of the female pelvis: a review. AJR Am J Roentgenol (1986) 1.06
Magnetic resonance imaging in the evaluation of abscesses. AJR Am J Roentgenol (1985) 1.05
The use and accuracy of cross-sectional imaging and fine needle aspiration cytology for detection of pelvic lymph node metastases before radical prostatectomy. J Urol (1995) 1.04
Nuclear magnetic resonance imaging of the cardiovascular system: normal and pathologic findings. Radiology (1983) 1.04
MR imaging evaluation of benign mesenchymal tumors of the urinary bladder. AJR Am J Roentgenol (1997) 1.04
Demyelinating events in early multiple sclerosis have inherent severity and recovery. Neurology (2009) 1.04
Inconclusive clinical and ultrasound evaluation of the scrotum: impact of magnetic resonance imaging on patient management and cost. Urology (1998) 1.02
Risk factors for herpes simplex virus epithelial keratitis recurring during treatment of stromal keratitis or iridocyclitis. Herpetic Eye Disease Study Group. Br J Ophthalmol (1996) 1.02
Undescended testis: value of MR imaging. Radiology (1987) 1.02
Cine gradient refocused echo (GRE) imaging of intravascular masses: differentiation between tumor and nontumor thrombus. J Comput Assist Tomogr (1992) 1.01
Serum beta 2-microglobulin decreases in patients with AIDS or ARC treated with azidothymidine. J Infect Dis (1989) 1.01
Positive fraction of systematic biopsies predicts risk of relapse after radical prostatectomy. Urology (1998) 1.01
The ovary. Computed tomography and magnetic resonance imaging. Radiol Clin North Am (1993) 1.00
Y chromosome deletions in azoospermic and severely oligozoospermic men undergoing intracytoplasmic sperm injection after testicular sperm extraction. Hum Reprod (1998) 1.00